Improving the solubility, activity, and stability of reteplase using in silico design of new variants
Reteplase (recombinant plasminogen activator, r-PA) is a thrombolytic agent recombined from tissue-type plasminogen activator (t-PA), which has several prominent features such as strong thrombolytic ability and E. coli expressibility. Despite these outstanding features, it demonstrates reduced fibri...
Main Authors: | Hooria Seyedhosseini Ghaheh, Mohamad Reza Ganjalikhany, Parichehreh Yaghmaei, Morteza Pourfarzam, Hamid Mir Mohammad Sadeghi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2019;volume=14;issue=4;spage=359;epage=368;aulast=Seyedhosseini |
Similar Items
-
Successful treatment of prosthetic pulmonary valve thrombosis with reteplase: a case report
by: Khameneh Bagheri R, et al.
Published: (2018-09-01) -
In Silico Study of Different Thrombolytic Agents for Fibrinolysis in Acute Ischemic Stroke
by: Yilin Yang, et al.
Published: (2023-02-01) -
An in vitro comparative study on clot lysis efficiency of urokinase and reteplase with the synergy of ultrasound needle
by: Junhui Tang, et al.
Published: (2024-03-01) -
Molecular cloning of Reteplase and its expression in E. coli using tac promoter
by: Safieh Aghaabdollahian, et al.
Published: (2014-01-01) -
Effect of buffer additives on solubilization and refolding of reteplase inclusion bodies
by: Iman Esmaili, et al.
Published: (2018-01-01)